Point-of-care testing (POCT), or bedside testing is defined as medical diagnostic testing at or near the point of careâthat is, at the time and place of patient care.[1] This contrasts with the historical pattern in which testing was wholly or mostly confined to the medical laboratory, which entailed sending off specimens away from the point of care ...
Generic OxyContin would have cost 25 per cent of the price for the brand-name product, according to Tam. Consumers must spend $251.85 for 100 40-milligram tablets of OxyNEO and $442.84 for 100 80-milligram tablets. The price was the same for OxyContin.
But the decision is also likely to result in higher prices for OxyContin, a time-release form of a narcotic called oxycodone, because it will not face generic competition. The decision by the F.D.A. came on the day when the patent for the original version of OxyContin was set to expire.